Nano-X Imaging (NASDAQ: NNOX) has entered into a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The announcement, made on September 11, 2026, highlights Nanox's ongoing efforts to drive the global transition to preventive health care through its integrated imaging platform.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support for the Nanox.ARC in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This move marks Nanox's third Latin American market this year, following entries into Argentina and Peru.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the broader Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs of chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions.
This expansion into Costa Rica is significant as it demonstrates Nanox's strategy to lower barriers to adoption of advanced medical imaging in emerging markets. By partnering with a local distributor that already supplies the CCSS, Nanox aims to improve access to 3D imaging, which can lead to earlier detection of diseases and improved patient outcomes. The agreement also underscores the growing demand for affordable, scalable imaging solutions in Latin America, where healthcare systems often face resource constraints.
For investors, this news signals continued progress in Nanox's commercialization efforts. The company's forward-looking statements caution that actual results may differ materially due to various risks and uncertainties, including regulatory and market factors. However, the successful deployment of the Nanox.ARC in Costa Rica could serve as a proof of concept for other markets in the region.
For more details, the full press release is available at https://ibn.fm/C77lJ. Additionally, the latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. Investors should review the full terms of use and disclaimers on the InvestorBrandNetwork website at https://IBN.ai/Disclaimer.
